Skip to main content

Table 1 Baseline characteristics (n = 75)

From: Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators

Characteristic

 

Age (mean ± SD, range)

50.9 ± 11.5, 29.2-77.4

CAGn (mean ± SD, range)

44.5 ± 3.4, 39-54

Women, n (%)

49 (65%)

Caucasian, n (%)

71 (95%)

Affected Parent, n (%)

 

   Mother

33 (44%)

   Father

33 (44%)

   Unspecified

9 (12%)

Years of Illness duration (mean ± SD, range)

8.5 ± 4.5, 1.9-25.9

History of Depression, n (%)

42 (56%)